Request for Covid-19 Impact Assessment of this Report
The United States Peramivir market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Peramivir market, reaching US$ million by the year 2028. As for the Europe Peramivir landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Peramivir players cover BioCryst Pharmaceuticals, Green Cross Pharma, Shionogi Co., and NeoPharm, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Peramivir market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Solution
Solid
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Influenza A Treatment
Influenza B Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi Co.
NeoPharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co., Ltd.
SCOLR Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Peramivir Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Peramivir by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Peramivir by Country/Region, 2017, 2022 & 2028
2.2 Peramivir Segment by Type
2.2.1 Solution
2.2.2 Solid
2.3 Peramivir Sales by Type
2.3.1 Global Peramivir Sales Market Share by Type (2017-2022)
2.3.2 Global Peramivir Revenue and Market Share by Type (2017-2022)
2.3.3 Global Peramivir Sale Price by Type (2017-2022)
2.4 Peramivir Segment by Application
2.4.1 Influenza A Treatment
2.4.2 Influenza B Treatment
2.5 Peramivir Sales by Application
2.5.1 Global Peramivir Sale Market Share by Application (2017-2022)
2.5.2 Global Peramivir Revenue and Market Share by Application (2017-2022)
2.5.3 Global Peramivir Sale Price by Application (2017-2022)
3 Global Peramivir by Company
3.1 Global Peramivir Breakdown Data by Company
3.1.1 Global Peramivir Annual Sales by Company (2020-2022)
3.1.2 Global Peramivir Sales Market Share by Company (2020-2022)
3.2 Global Peramivir Annual Revenue by Company (2020-2022)
3.2.1 Global Peramivir Revenue by Company (2020-2022)
3.2.2 Global Peramivir Revenue Market Share by Company (2020-2022)
3.3 Global Peramivir Sale Price by Company
3.4 Key Manufacturers Peramivir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Peramivir Product Location Distribution
3.4.2 Players Peramivir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Peramivir by Geographic Region
4.1 World Historic Peramivir Market Size by Geographic Region (2017-2022)
4.1.1 Global Peramivir Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Peramivir Annual Revenue by Geographic Region
4.2 World Historic Peramivir Market Size by Country/Region (2017-2022)
4.2.1 Global Peramivir Annual Sales by Country/Region (2017-2022)
4.2.2 Global Peramivir Annual Revenue by Country/Region
4.3 Americas Peramivir Sales Growth
4.4 APAC Peramivir Sales Growth
4.5 Europe Peramivir Sales Growth
4.6 Middle East & Africa Peramivir Sales Growth
5 Americas
5.1 Americas Peramivir Sales by Country
5.1.1 Americas Peramivir Sales by Country (2017-2022)
5.1.2 Americas Peramivir Revenue by Country (2017-2022)
5.2 Americas Peramivir Sales by Type
5.3 Americas Peramivir Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peramivir Sales by Region
6.1.1 APAC Peramivir Sales by Region (2017-2022)
6.1.2 APAC Peramivir Revenue by Region (2017-2022)
6.2 APAC Peramivir Sales by Type
6.3 APAC Peramivir Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Peramivir by Country
7.1.1 Europe Peramivir Sales by Country (2017-2022)
7.1.2 Europe Peramivir Revenue by Country (2017-2022)
7.2 Europe Peramivir Sales by Type
7.3 Europe Peramivir Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peramivir by Country
8.1.1 Middle East & Africa Peramivir Sales by Country (2017-2022)
8.1.2 Middle East & Africa Peramivir Revenue by Country (2017-2022)
8.2 Middle East & Africa Peramivir Sales by Type
8.3 Middle East & Africa Peramivir Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Peramivir
10.3 Manufacturing Process Analysis of Peramivir
10.4 Industry Chain Structure of Peramivir
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Peramivir Distributors
11.3 Peramivir Customer
12 World Forecast Review for Peramivir by Geographic Region
12.1 Global Peramivir Market Size Forecast by Region
12.1.1 Global Peramivir Forecast by Region (2023-2028)
12.1.2 Global Peramivir Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Peramivir Forecast by Type
12.7 Global Peramivir Forecast by Application
13 Key Players Analysis
13.1 BioCryst Pharmaceuticals
13.1.1 BioCryst Pharmaceuticals Company Information
13.1.2 BioCryst Pharmaceuticals Peramivir Product Offered
13.1.3 BioCryst Pharmaceuticals Peramivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 BioCryst Pharmaceuticals Main Business Overview
13.1.5 BioCryst Pharmaceuticals Latest Developments
13.2 Green Cross Pharma
13.2.1 Green Cross Pharma Company Information
13.2.2 Green Cross Pharma Peramivir Product Offered
13.2.3 Green Cross Pharma Peramivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Green Cross Pharma Main Business Overview
13.2.5 Green Cross Pharma Latest Developments
13.3 Shionogi Co.
13.3.1 Shionogi Co. Company Information
13.3.2 Shionogi Co. Peramivir Product Offered
13.3.3 Shionogi Co. Peramivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Shionogi Co. Main Business Overview
13.3.5 Shionogi Co. Latest Developments
13.4 NeoPharm
13.4.1 NeoPharm Company Information
13.4.2 NeoPharm Peramivir Product Offered
13.4.3 NeoPharm Peramivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 NeoPharm Main Business Overview
13.4.5 NeoPharm Latest Developments
13.5 Moksha8 Pharma
13.5.1 Moksha8 Pharma Company Information
13.5.2 Moksha8 Pharma Peramivir Product Offered
13.5.3 Moksha8 Pharma Peramivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Moksha8 Pharma Main Business Overview
13.5.5 Moksha8 Pharma Latest Developments
13.6 NT Pharma
13.6.1 NT Pharma Company Information
13.6.2 NT Pharma Peramivir Product Offered
13.6.3 NT Pharma Peramivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 NT Pharma Main Business Overview
13.6.5 NT Pharma Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck Peramivir Product Offered
13.7.3 Merck Peramivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
13.8 Hikma Pharmaceuticals
13.8.1 Hikma Pharmaceuticals Company Information
13.8.2 Hikma Pharmaceuticals Peramivir Product Offered
13.8.3 Hikma Pharmaceuticals Peramivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hikma Pharmaceuticals Main Business Overview
13.8.5 Hikma Pharmaceuticals Latest Developments
13.9 Hunan Nucien Pharmaceutical Co., Ltd.
13.9.1 Hunan Nucien Pharmaceutical Co., Ltd. Company Information
13.9.2 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Offered
13.9.3 Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hunan Nucien Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Hunan Nucien Pharmaceutical Co., Ltd. Latest Developments
13.10 SCOLR Pharma
13.10.1 SCOLR Pharma Company Information
13.10.2 SCOLR Pharma Peramivir Product Offered
13.10.3 SCOLR Pharma Peramivir Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 SCOLR Pharma Main Business Overview
13.10.5 SCOLR Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Peramivir Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Peramivir Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Solution
Table 4. Major Players of Solid
Table 5. Global Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 6. Global Peramivir Sales Market Share by Type (2017-2022)
Table 7. Global Peramivir Revenue by Type (2017-2022) & ($ million)
Table 8. Global Peramivir Revenue Market Share by Type (2017-2022)
Table 9. Global Peramivir Sale Price by Type (2017-2022) & (US$/Kg)
Table 10. Global Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 11. Global Peramivir Sales Market Share by Application (2017-2022)
Table 12. Global Peramivir Revenue by Application (2017-2022)
Table 13. Global Peramivir Revenue Market Share by Application (2017-2022)
Table 14. Global Peramivir Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Peramivir Sales by Company (2020-2022) & (Kilotons)
Table 16. Global Peramivir Sales Market Share by Company (2020-2022)
Table 17. Global Peramivir Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Peramivir Revenue Market Share by Company (2020-2022)
Table 19. Global Peramivir Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Peramivir Producing Area Distribution and Sales Area
Table 21. Players Peramivir Products Offered
Table 22. Peramivir Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Peramivir Sales by Geographic Region (2017-2022) & (Kilotons)
Table 26. Global Peramivir Sales Market Share Geographic Region (2017-2022)
Table 27. Global Peramivir Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Peramivir Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Peramivir Sales by Country/Region (2017-2022) & (Kilotons)
Table 30. Global Peramivir Sales Market Share by Country/Region (2017-2022)
Table 31. Global Peramivir Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Peramivir Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Peramivir Sales by Country (2017-2022) & (Kilotons)
Table 34. Americas Peramivir Sales Market Share by Country (2017-2022)
Table 35. Americas Peramivir Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Peramivir Revenue Market Share by Country (2017-2022)
Table 37. Americas Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 38. Americas Peramivir Sales Market Share by Type (2017-2022)
Table 39. Americas Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 40. Americas Peramivir Sales Market Share by Application (2017-2022)
Table 41. APAC Peramivir Sales by Region (2017-2022) & (Kilotons)
Table 42. APAC Peramivir Sales Market Share by Region (2017-2022)
Table 43. APAC Peramivir Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Peramivir Revenue Market Share by Region (2017-2022)
Table 45. APAC Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 46. APAC Peramivir Sales Market Share by Type (2017-2022)
Table 47. APAC Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 48. APAC Peramivir Sales Market Share by Application (2017-2022)
Table 49. Europe Peramivir Sales by Country (2017-2022) & (Kilotons)
Table 50. Europe Peramivir Sales Market Share by Country (2017-2022)
Table 51. Europe Peramivir Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Peramivir Revenue Market Share by Country (2017-2022)
Table 53. Europe Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 54. Europe Peramivir Sales Market Share by Type (2017-2022)
Table 55. Europe Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 56. Europe Peramivir Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Peramivir Sales by Country (2017-2022) & (Kilotons)
Table 58. Middle East & Africa Peramivir Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Peramivir Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Peramivir Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Peramivir Sales by Type (2017-2022) & (Kilotons)
Table 62. Middle East & Africa Peramivir Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Peramivir Sales by Application (2017-2022) & (Kilotons)
Table 64. Middle East & Africa Peramivir Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Peramivir
Table 66. Key Market Challenges & Risks of Peramivir
Table 67. Key Industry Trends of Peramivir
Table 68. Peramivir Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Peramivir Distributors List
Table 71. Peramivir Customer List
Table 72. Global Peramivir Sales Forecast by Region (2023-2028) & (Kilotons)
Table 73. Global Peramivir Sales Market Forecast by Region
Table 74. Global Peramivir Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Peramivir Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Peramivir Sales Forecast by Country (2023-2028) & (Kilotons)
Table 77. Americas Peramivir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Peramivir Sales Forecast by Region (2023-2028) & (Kilotons)
Table 79. APAC Peramivir Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Peramivir Sales Forecast by Country (2023-2028) & (Kilotons)
Table 81. Europe Peramivir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Peramivir Sales Forecast by Country (2023-2028) & (Kilotons)
Table 83. Middle East & Africa Peramivir Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Peramivir Sales Forecast by Type (2023-2028) & (Kilotons)
Table 85. Global Peramivir Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Peramivir Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Peramivir Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Peramivir Sales Forecast by Application (2023-2028) & (Kilotons)
Table 89. Global Peramivir Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Peramivir Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Peramivir Revenue Market Share Forecast by Application (2023-2028)
Table 92. BioCryst Pharmaceuticals Basic Information, Peramivir Manufacturing Base, Sales Area and Its Competitors
Table 93. BioCryst Pharmaceuticals Peramivir Product Offered
Table 94. BioCryst Pharmaceuticals Peramivir Sales (Kilotons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. BioCryst Pharmaceuticals Main Business
Table 96. BioCryst Pharmaceuticals Latest Developments
Table 97. Green Cross Pharma Basic Information, Peramivir Manufacturing Base, Sales Area and Its Competitors
Table 98. Green Cross Pharma Peramivir Product Offered
Table 99. Green Cross Pharma Peramivir Sales (Kilotons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. Green Cross Pharma Main Business
Table 101. Green Cross Pharma Latest Developments
Table 102. Shionogi Co. Basic Information, Peramivir Manufacturing Base, Sales Area and Its Competitors
Table 103. Shionogi Co. Peramivir Product Offered
Table 104. Shionogi Co. Peramivir Sales (Kilotons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. Shionogi Co. Main Business
Table 106. Shionogi Co. Latest Developments
Table 107. NeoPharm Basic Information, Peramivir Manufacturing Base, Sales Area and Its Competitors
Table 108. NeoPharm Peramivir Product Offered
Table 109. NeoPharm Peramivir Sales (Kilotons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. NeoPharm Main Business
Table 111. NeoPharm Latest Developments
Table 112. Moksha8 Pharma Basic Information, Peramivir Manufacturing Base, Sales Area and Its Competitors
Table 113. Moksha8 Pharma Peramivir Product Offered
Table 114. Moksha8 Pharma Peramivir Sales (Kilotons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Moksha8 Pharma Main Business
Table 116. Moksha8 Pharma Latest Developments
Table 117. NT Pharma Basic Information, Peramivir Manufacturing Base, Sales Area and Its Competitors
Table 118. NT Pharma Peramivir Product Offered
Table 119. NT Pharma Peramivir Sales (Kilotons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. NT Pharma Main Business
Table 121. NT Pharma Latest Developments
Table 122. Merck Basic Information, Peramivir Manufacturing Base, Sales Area and Its Competitors
Table 123. Merck Peramivir Product Offered
Table 124. Merck Peramivir Sales (Kilotons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Merck Main Business
Table 126. Merck Latest Developments
Table 127. Hikma Pharmaceuticals Basic Information, Peramivir Manufacturing Base, Sales Area and Its Competitors
Table 128. Hikma Pharmaceuticals Peramivir Product Offered
Table 129. Hikma Pharmaceuticals Peramivir Sales (Kilotons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Hikma Pharmaceuticals Main Business
Table 131. Hikma Pharmaceuticals Latest Developments
Table 132. Hunan Nucien Pharmaceutical Co., Ltd. Basic Information, Peramivir Manufacturing Base, Sales Area and Its Competitors
Table 133. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Product Offered
Table 134. Hunan Nucien Pharmaceutical Co., Ltd. Peramivir Sales (Kilotons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Hunan Nucien Pharmaceutical Co., Ltd. Main Business
Table 136. Hunan Nucien Pharmaceutical Co., Ltd. Latest Developments
Table 137. SCOLR Pharma Basic Information, Peramivir Manufacturing Base, Sales Area and Its Competitors
Table 138. SCOLR Pharma Peramivir Product Offered
Table 139. SCOLR Pharma Peramivir Sales (Kilotons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 140. SCOLR Pharma Main Business
Table 141. SCOLR Pharma Latest Developments
List of Figures
Figure 1. Picture of Peramivir
Figure 2. Peramivir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Peramivir Sales Growth Rate 2017-2028 (Kilotons)
Figure 7. Global Peramivir Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Peramivir Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Solution
Figure 10. Product Picture of Solid
Figure 11. Global Peramivir Sales Market Share by Type in 2021
Figure 12. Global Peramivir Revenue Market Share by Type (2017-2022)
Figure 13. Peramivir Consumed in Influenza A Treatment
Figure 14. Global Peramivir Market: Influenza A Treatment (2017-2022) & (Kilotons)
Figure 15. Peramivir Consumed in Influenza B Treatment
Figure 16. Global Peramivir Market: Influenza B Treatment (2017-2022) & (Kilotons)
Figure 17. Global Peramivir Sales Market Share by Application (2017-2022)
Figure 18. Global Peramivir Revenue Market Share by Application in 2021
Figure 19. Peramivir Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Peramivir Revenue Market Share by Company in 2021
Figure 21. Global Peramivir Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Peramivir Revenue Market Share by Geographic Region in 2021
Figure 23. Global Peramivir Sales Market Share by Region (2017-2022)
Figure 24. Global Peramivir Revenue Market Share by Country/Region in 2021
Figure 25. Americas Peramivir Sales 2017-2022 (Kilotons)
Figure 26. Americas Peramivir Revenue 2017-2022 ($ Millions)
Figure 27. APAC Peramivir Sales 2017-2022 (Kilotons)
Figure 28. APAC Peramivir Revenue 2017-2022 ($ Millions)
Figure 29. Europe Peramivir Sales 2017-2022 (Kilotons)
Figure 30. Europe Peramivir Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Peramivir Sales 2017-2022 (Kilotons)
Figure 32. Middle East & Africa Peramivir Revenue 2017-2022 ($ Millions)
Figure 33. Americas Peramivir Sales Market Share by Country in 2021
Figure 34. Americas Peramivir Revenue Market Share by Country in 2021
Figure 35. United States Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Peramivir Sales Market Share by Region in 2021
Figure 40. APAC Peramivir Revenue Market Share by Regions in 2021
Figure 41. China Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Peramivir Sales Market Share by Country in 2021
Figure 48. Europe Peramivir Revenue Market Share by Country in 2021
Figure 49. Germany Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Peramivir Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Peramivir Revenue Market Share by Country in 2021
Figure 56. Egypt Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Peramivir Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Peramivir in 2021
Figure 62. Manufacturing Process Analysis of Peramivir
Figure 63. Industry Chain Structure of Peramivir
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...